{"id":"NCT02388906","sponsor":"Bristol-Myers Squibb","briefTitle":"Efficacy Study of Nivolumab Compared to Ipilimumab in Prevention of Recurrence of Melanoma After Complete Resection of Stage IIIb/c or Stage IV Melanoma","officialTitle":"A Phase 3, Randomized, Double-blind Study of Adjuvant Immunotherapy With Nivolumab Versus Ipilimumab After Complete Resection of Stage IIIb/c or Stage IV Melanoma in Subjects Who Are at High Risk for Recurrence (CheckMate 238: CHECKpoint Pathway and nivoluMAb Clinical Trial Evaluation 238)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2015-03-16","primaryCompletion":"2018-11-26","completion":"2024-10-16","firstPosted":"2015-03-17","resultsPosted":"2021-06-15","lastUpdate":"2025-04-24"},"enrollment":906,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Melanoma"],"interventions":[{"type":"DRUG","name":"Ipilimumab","otherNames":[]},{"type":"DRUG","name":"Nivolumab","otherNames":[]},{"type":"OTHER","name":"Placebo matching Ipilimumab","otherNames":[]},{"type":"OTHER","name":"Placebo matching Nivolumab","otherNames":[]}],"arms":[{"label":"Ipilimumab and Placebo matching Nivolumab","type":"EXPERIMENTAL"},{"label":"Nivolumab and Placebo matching Ipilimumab","type":"EXPERIMENTAL"}],"summary":"The purpose of this study is to determine whether nivolumab is better than ipilimumab to prevent recurrence of melanoma.","primaryOutcome":{"measure":"Recurrence-free Survival (RFS)","timeFrame":"up to 36 months","effectByArm":[{"arm":"Nivolumab 3 mg/kg","deltaMin":52.37,"sd":null},{"arm":"Ipilimumab 10 mg/kg","deltaMin":24.08,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.0003"}]},"eligibility":{"minAge":"15 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":4},"locations":{"siteCount":136,"countries":["United States","Argentina","Australia","Austria","Belgium","Canada","Czechia","Finland","France","Greece","Hungary","Ireland","Italy","Japan","Netherlands","Norway","Poland","Romania","South Africa","South Korea","Spain","Sweden","Switzerland","Taiwan","United Kingdom"]},"refs":{"pmids":["39378385","39102624","35964471","34663559","34452930","32961119","28891423"],"seeAlso":["https://www.bms.com/researchers-and-partners/clinical-trials-and-research.html","https://www.BMSClinicalTrials.com"]},"adverseEventsSummary":{"seriousAny":{"events":106,"n":452},"commonTop":["Diarrhoea","Fatigue","Pruritus","Rash","Headache"]}}